CCDC132 Activators
CCDC132 Activators, as inferred from the compounds listed above, are diverse and impact various biological processes that could indirectly enhance the activity of CCDC132. Compounds like NAD+ and Forskolin might impact the function of CCDC132 by modulating the activity of proteins through post-translational modifications or by altering intracellular signaling cascades, respectively. For instance, NAD+-dependent deacetylation by sirtuins can change the interaction landscape of vesicular trafficking proteins, which may enhance the functional activity of CCDC132 by promoting its interaction with other proteins or by stabilizing its active form.
Other compounds, such as Jasplakinolide, Paclitaxel, and Latrunculin A, impact the cytoskeleton, a critical component for vesicle movement within the cell. Jasplakinolide stabilizes actin filaments, enhancing the ability of CCDC132 to facilitate vesicular motility if it interacts with actin. Conversely, Latrunculin A disrupts actin polymerization, which can lead to changes in vesicle transport dynamics that may require the upregulation or enhanced activity of proteins like CCDC132 to compensate for cytoskeletal disruption. Similarly, compounds affecting microtubules, such as Paclitaxel, may enhance CCDC132's activity by stabilizing microtubules and promoting microtubule-dependent vesicle transport. Microtubules are highways for intracellular trafficking, and stabilizing them could improve the efficiency of vesicular transport mechanisms, involving CCDC132.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that disrupts intracellular ion gradients. By altering vesicular pH, monensin could indirectly enhance CCDC132's function in sorting or trafficking by changing the vesicular membrane potential. | ||||||
Guanabenz acetate | 23256-50-0 | sc-203590 sc-203590A sc-203590B sc-203590C sc-203590D | 100 mg 500 mg 1 g 10 g 25 g | $102.00 $468.00 $832.00 $4162.00 $7283.00 | 2 | |
Guanabenz, which modulates Clathrin-mediated endocytosis, can affect the recycling of membrane proteins and vesicles. This modulation might enhance CCDC132's activity in vesicular formation or targeting. | ||||||
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $69.00 $214.00 $796.00 $1918.00 | 19 | |
NEM selectively modifies cysteine residues and can disrupt protein-protein interactions. By modifying partners of CCDC132, NEM could indirectly increase the functional activity of CCDC132 by changing its interactome. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a GTPase inhibitor that affects Dynamin, involved in vesicle scission. Inhibiting Dynamin can lead to compensatory mechanisms that enhance CCDC132 function in vesicle formation or trafficking. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule polymerization. By altering cytoskeletal dynamics, it could enhance CCDC132's role in microtubule-dependent vesicle transport. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases, which can lead to alterations in membrane trafficking. Through this inhibition, CCDC132's role in vesicular trafficking could be enhanced as part of a cellular compensatory response. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin polymerization. By modifying the actin cytoskeleton, it could indirectly enhance the function of CCDC132 in actin-dependent vesicle movement. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A inhibits transport from the ER to the Golgi apparatus. This disruption could enhance the role of CCDC132 in vesicular trafficking pathways as cells attempt to compensate for the blockade. | ||||||
Benzyl alcohol | 100-51-6 | sc-326216B sc-326216 sc-326216A | 250 ml 1 L 5 L | $32.00 $104.00 $416.00 | ||
Benzyl alcohol affects membrane fluidity and permeability. By altering these properties, it could indirectly enhance the functional activity of CCDC132 in vesicular trafficking or fusion events. | ||||||
2-Hydroxypropyl-β-cyclodextrin | 128446-35-5 | sc-203461 sc-203461B sc-203461C sc-203461A | 1 g 100 g 500 g 5 g | $53.00 $620.00 $1989.00 $133.00 | 8 | |
This compound extracts cholesterol from membranes, disrupting lipid rafts. This disruption could enhance CCDC132's function by altering the distribution or localization of trafficking proteins involved in vesicle formation. | ||||||